CD274 and cervical carcinoma: Immune checkpoint blockade (ICB) with programmed cell death (ligand)-1 [PD-(L)1] inhibitors is a promising approach to HPV-driven malignancy based on clinical experience in head and neck squamous cell carcinoma (HNSCC) (14) and cervical cancer (15).